1. Home
  2. AAON vs RYTM Comparison

AAON vs RYTM Comparison

Compare AAON & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AAON Inc.

AAON

AAON Inc.

N/A

Current Price

$80.65

Market Cap

6.1B

Sector

Industrials

ML Signal

N/A

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

N/A

Current Price

$115.27

Market Cap

6.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AAON
RYTM
Founded
1988
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
6.3B
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
AAON
RYTM
Price
$80.65
$115.27
Analyst Decision
Buy
Strong Buy
Analyst Count
6
19
Target Price
$117.50
★ $140.12
AVG Volume (30 Days)
1.5M
★ 1.5M
Earning Date
11-09-2026
11-03-2026
Dividend Yield
★ 0.51%
N/A
EPS Growth
N/A
★ 28.34
EPS
★ 2.06
N/A
Revenue
★ $1,442,076,000.00
N/A
Revenue This Year
$74.10
$73.80
Revenue Next Year
$16.48
$73.86
P/E Ratio
$38.29
★ N/A
Revenue Growth
★ 20.11
N/A
52 Week Low
$53.13
$74.50
52 Week High
$150.46
$122.20

Technical Indicators

Market Signals
Indicator
AAON
RYTM
Relative Strength Index (RSI) 58.07 65.94
Support Level $75.32 $82.31
Resistance Level $89.67 $119.75
Average True Range (ATR) 6.02 6.84
MACD 1.92 2.19
Stochastic Oscillator 82.29 94.00

Price Performance

Historical Comparison
AAON
RYTM

About AAON AAON Inc.

AAON Inc is a manufacturer of air-conditioning and heating equipment. The products include rooftop units, chillers, packaged outdoor mechanical rooms, air-handling units, makeup air units, energy-recovery units, condensing units, geothermal heat pumps, and self-contained units and coils. The company operates through three segments: AAON Oklahoma, AAON Coil Products, and BASX. It generates the majority of its revenue from the AAON Oklahoma segment which derives maximum revenue, engineers, manufactures, and sells, semi-custom, and custom HVAC systems, designs and manufactures control solutions, and sells retail parts to customers through retail part stores and online.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Share on Social Networks: